Program Lead for Nuclear Medicine (Physician) to provide strategic and clinical leadership for our growing molecular imaging and theranostics program.
This is a unique opportunity to join one of the nation's leading community-based theranostics programs and play a key role in shaping the future of precision oncology.
Position Highlights- Lead and expand nuclear medicine services across a large, innovative oncology practice.
- Provide oversight for Nuclear Medicine, SPECT/SPECT-CT, PET-CT, and theranostics.
- Serve as the practice's Authorized User (AU), advising on emerging radiopharmaceuticals and therapeutic agents.
- Collaborate with physician leaders, industry partners, and multidisciplinary teams.
- Participate in clinical research and serve as a Principal Investigator for clinical trials.
Why Nebraska Cancer Specialists?- Nationally recognized theranostics program
- Robust Phase I-III clinical trials program, including radiopharmaceutical and theranostics studies
- Experienced, fully supported research team
- Dedicated multidisciplinary tumor boards
- In-house PET, CT, bone scan, and MUGA imaging
- Multiple full-service infusion centers and outpatient specialty pharmacy
- ASCT, CAR-T, and bispecific therapy capabilities
- Opportunities to teach and mentor through local academic affiliations
Compensation & Benefits- Competitive salary and performance bonus
- Flexible on-site or remote options
- Generous PTO
- Employee-paid comprehensive medical, dental, and vision coverage
- Employer-paid life and long-term disability insurance
- 401(k) with employer contribution
- Malpractice coverage
- Licensure and certification reimbursement
Requirements
- MD or DO
- Board Certified in Nuclear Medicine (ABNM) or Nuclear Radiology (ABR/ABNM)
- Significant experience in PET/CT, Molecular Imaging, and theranostics
- Strong leadership, communication, and collaboration skills
- Commitment to compassionate, patient-centered care
Join Nebraska Cancer Specialists and help advance the next generation of molecular imaging and precision cancer care. 
